Baxter Canadian Hemophilia Epidemiological Research Program
The goal of the Baxter Canadian Hemophilia Epidemiological Research Program (B-CHERP) is to provide Canadian investigators with new resources to conduct quality population-based clinical research in hereditary bleeding disorders in Canada. It is hoped that proposals will capitalize on the existing network of comprehensive care hemophilia clinics throughout Canada and assets such as the Canadian Hemophilia Assessment and Resource Management System (CHARMS). However, this will not be a limiting condition. 
Application Cycle
Calls for applications will go out in the summer with a deadline for submission of March 15th. The results of the competition will be announced by May 1st and funding will be disbursed by June 1st. Candidates that are applying for the renewal of a grant already funded will have until November 1st to submit updated results to support continued funding in the following year.
BAXTER’S PARTNERSHIP WITH AHCDC
Since 2005 Baxter and the Association of Hemophilia Clinic Directors of Canada (AHCDC) have entered into a partnership to advance hemophilia research in Canada.
GRANTS AVAILABLE
One to 3 research proposals will be funded every year, each with a maximum grant of $75,000 annually.
RESEARCH TYPE & SCOPE
The program will support and fund clinical, descriptive and epidemiological studies of hereditary bleeding disorders.